TT232, A Novel Signal Transduction Inhibitory Compound in the Therapy of Cancer and Inflammatory Diseases

Author: SZOKOLÓCZI ORSOLYA   SCHWAB RICHÁRD   PETÁK ISTVÁN   ÖRFI LÁSZLÓ   PAP ÁKOS   EBERLE ALEX   SZÜTS TAMÁS   KÉRI1 GYÖRGY  

Publisher: Informa Healthcare

ISSN: 1079-9893

Source: Journal of Receptors and Signal Transduction, Vol.25, Iss.4-6, 2005-07, pp. : 217-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract